BioMarin Pharmaceutical Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
3 Biotech Stocks Up In The Past Month On Industry Turnaround
Article By: Zacks Investment Research
Tuesday, June 5, 2018 1:08 PM EST
After a strong start in 2018, the drug sector struggled a bit in the next few months probably on U.S. market instability and a few negative updates on the pipeline and regulatory front.
In this article: BMRN, LGND, VVUS Also: JNJ
Read
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld
Monday, January 15, 2018 9:00 PM EST
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
XBI Breaks Through On A Strong Week For Biotech
Article By: Rod Raynovich
Friday, September 29, 2017 7:25 PM EST
The XBI is up 3.17% this week, 46% YTD, compared to only 1.1% WTD for the IBB. The breakthrough gains for the XBI can be attributed to strong performance of top ten holdings that are primarily mid-caps and M&A prospects.
In this article: BMY, ALNY, BMRN, IBB, AMGN, CELG, CLVS, XBI, JUNO, PBYI, SRPT, BLUE, PTCT, ABBV, FMI
Read
Reading The Tape Of Biomarin Pharma
Video By: readtheticker
Friday, September 15, 2017 11:34 AM EST
Biotechs are recovering and Biomarin Pharma's stock is lagging, but getting ready to move.
In this video: BMRN
Watch
Citi Starts BioMarin At Buy With $169 Per Share 'Blue Sky Scenario'
Article By: The Fly
Wednesday, August 30, 2017 10:25 AM EST
Citi analyst Robyn Karnauskas started BioMarin with a Buy rating and $98 price target.
In this article: BMRN
Read

PARTNER HEADLINES

Latest Tweets for $BMRN

No tweets yet!